Results 251 to 260 of about 351,631 (301)
Some of the next articles are maybe not open access.
End-stage liver disease complications
Current Opinion in Gastroenterology, 2013Chronic liver disease causes significant morbidity and mortality because of any number of complications including hepatic encephalopathy, ascites, hepatorenal syndrome (HRS), and esophageal variceal hemorrhage (EVH).Predictors of response to lactulose, probiotics, and L-ornithine-L-aspartate therapy in minimal hepatic encephalopathy (MHE) have been ...
Robert S, Rahimi, Don C, Rockey
openaire +2 more sources
Nutrition in end stage liver disease
Best Practice & Research Clinical Gastroenterology, 2006This chapter will focus on studies within the last 5 years of nutrition in end stage liver disease, but earlier studies illustrating the present state of affairs will also be mentioned. The first part will focus on descriptive epidemiological studies that help to set the scene for the intervention studies, which will be described in the second part ...
openaire +3 more sources
Infectious Diseases in End-Stage Liver Disease Patients
Critical Care Nursing Clinics of North America, 2010Patients with chronic liver diseases sustain impairment to immune systems, which worsens over time. These defects in their host defense lead to risks of bacterial infections and increased morbidity. Providers should have heightened surveillance for infectious diseases and suspect one with any acute change in status.
Aneesh K, Mehta, G Marshall, Lyon
openaire +2 more sources
Mortality in patients with end‐stage liver disease above model for end‐stage liver disease 3.0 of 40
Hepatology, 2023Background and Aims: Since the implementation of the model for end‐stage liver disease (MELD) score to determine waitlist priority for liver transplant (LT) in 2002, the score has been capped at 40. Recently, the MELD 3.0 score was proposed to improve upon MELD‐Na. Here, we examine waitlist mortality and LT outcomes in patients
W. Ray Kim +4 more
openaire +2 more sources
End-stage liver disease in children
Current Treatment Options in Gastroenterology, 2001The treatment of children with end-stage liver disease involves the coordinated management of nutritional deficiencies, ascites, pruritus, encephalopathy, and portal hypertension. The implementation of management strategies depends upon a parent or guardian to administer the plan in the context of a child at different stages of developmental ...
openaire +2 more sources
Infections in Patients With End-stage Liver Disease
Journal of Clinical Gastroenterology, 2007Infections in patients with end-stage liver disease (ESLD) are an important cause of morbidity and mortality in these patients. Abnormalities in their natural defense mechanisms, alterations in the enteric flora and the growing utilization of invasive procedures increase the risk of infections in these patients.
Rekha, Cheruvattath, Vijayan, Balan
openaire +2 more sources
Management of End-stage Liver Disease
Medical Clinics of North America, 2014Patients with cirrhosis who experience hepatic decompensation, such as the development of ascites, SBP, variceal hemorrhage, or hepatic encephalopathy, or who develop HCC, are at a higher risk of mortality. Management should be focused on the prevention of recurrence of complications, and these patients should be referred for consideration of liver ...
openaire +2 more sources
End‐stage renal disease in liver transplants
Clinical Transplantation, 2001Renal dysfunction is one of the most significant problems following orthotopic liver transplantation (OLTx). Since the major risk factor for delayed renal dysfunction following OLTx is presumed to be cyclosporine (CsA) nephrotoxicity, it has been suggested that CsA is the most probably cause of end‐stage renal disease (ESRD) in this population of ...
M, Lynn +3 more
openaire +2 more sources
Glomerulonephritis with end-stage liver disease in childhood
The Lancet, 1992Renal biopsies were done perioperatively in 18 children receiving liver grafts. All specimens showed glomerulonephritis, which was mesangial-proliferative in 15 and mesangio-capillary in 3. Of the 16 children who were alive four or more months after transplantation, only 1 showed progressive deterioration of renal function; 1 other had a subnormal but ...
G, Noble-Jamieson +4 more
openaire +2 more sources
Paediatrics and Child Health, 2013
Abstract Around 1200 children in the UK are under surveillance after liver transplantation for end stage liver disease (ESLD) and about 600 additional children have ESLD, but are not yet in need of transplantation. ESLD occurs in the context of extensive structural liver damage in which blood flow through the sinusoids, and the production and ...
openaire +1 more source
Abstract Around 1200 children in the UK are under surveillance after liver transplantation for end stage liver disease (ESLD) and about 600 additional children have ESLD, but are not yet in need of transplantation. ESLD occurs in the context of extensive structural liver damage in which blood flow through the sinusoids, and the production and ...
openaire +1 more source